As mentioned, very much doubt Jangho is in it for 30/50 cent short term gain. Their website reveals redirection into healthcare. I suspect bigger plans to come.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025